Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2014

Preliminary results of aflibercept in treatment naïve choroidal neovascularization of neovascular age-related macular degeneration

Sandrine A Zweifel; Christoph Amstutz; Johannes Fleischhauer; Malaika Kurz-Levin; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3942.

ARVO Annual Meeting Abstract March 2012

Long-term Studies On The Anti-VEGF Treatment Success In Age-related Macular Degeneration (amd)

Barbara Kloeckener-Gruissem; Moreno Menghini; Florian Sutter; Johannes Fleischhauer; Malaika Kurz-Levin; Wolfgang Berger; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5168.

Genetics June 2011

Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD

PDF

Barbara Kloeckener-Gruissem; Daniel Barthelmes; Stephan Labs; Christian Schindler; Malaika Kurz-Levin; Stephan Michels; Johannes Fleischhauer; Wolfgang Berger; Florian Sutter; Moreno Menghini
TAGS: exudative age-related macular degeneration, genetics, ranibizumab, single nucleotide polymorphism, genotype, genetic aspects
Invest. Ophthalmol. Vis. Sci.. 2011; 52(7):4694-4702. https://doi.org/10.1167/iovs.10-6080

ARVO Annual Meeting Abstract April 2011

A Swiss Patient Cohort Reveals Genetic Predisposition Of Known And New Genetic Loci To AMD And To Intravitreal Ranibizumab (lucentis®) Treatment Outcome

Barbara Kloeckener-Gruissem; Moreno Menghini; Daniel Barthelmes; Stephan Labs; Malaika Kurz-Levin; Stephan Michels; Johannes Fleischhauer; Florian Sutter; Wolfgang Berger

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5249.

ARVO Annual Meeting Abstract April 2010

Ranibizumab for Exudative Age Related Macular Degeneration - A Comparison of Treatment Results in Centres from Australia and Switzerland

D. Barthelmes; M. Menghini; F. K. P. Sutter; M. M. Kurz-Levin; J. C. Fleischhauer; M. C. Gillies

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):98.

ARVO Annual Meeting Abstract April 2010

Genetic Association of Known Risk Alleles With Different Lesion Types in Age-Related Macular Degeneration

J. C. Fleischhauer; M. Menghini; D. Barthelmes; W. Berger; S. Labs; M. Kurz-Levin; B. Kloeckener-Gruissem; S. Michels; F. Sutter

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1266.

ARVO Annual Meeting Abstract April 2010

Association Between Response to Intravitreal Ranibizumab and Known AMD Susceptibility Loci in Age-Related Macular Degeneration

M. Menghini; F. Sutter; W. Berger; J. Fleischhauer; S. Labs; M. Kurz-Levin; B. Kloeckener-Gruissem; S. Michels; D. Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1284.

ARVO Annual Meeting Abstract April 2009

Normalization of Functional and Anatomic Changes in Carcinoma Associated Retinopathy

S. Michels; D. Barthelmes; C. Amstutz; M. Kurz-Levin

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):338.

ARVO Annual Meeting Abstract May 2008

Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization Not Related to Age-Related Macular Degeneration

S. Michels; F. Sutter; H. Kordic; D. Barthelmes; M. Kurz-Levin

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2722.

ARVO Annual Meeting Abstract May 2008

Towards an Optimized Treatment Scheme of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: Subanalysis of Clinical Trial Data and Clinical Routine Use

F. K. Sutter; M. M. Kurz-Levin

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2884.

ARVO Annual Meeting Abstract May 2008

Intravitreal Anti-VEGF Therapy in Von Hippel-Lindau Disease With Retinal Angiomas

M. M. Kurz-Levin; S. Michels; E. Messmer; F. K. Sutter

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5686.

Clinical and Epidemiologic Research April 2007

Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?

PDF

Florian K. P. Sutter; Moreno Menghini; Daniel Barthelmes; Johannes C. Fleischhauer; Malaika M. Kurz-Levin; Martina M. Bosch; Horst Helbig
TAGS: exudative age-related macular degeneration, pseudophakia, risk factors, eye, cataract surgery
Invest. Ophthalmol. Vis. Sci.. 2007; 48(4):1472-1475. https://doi.org/10.1167/iovs.06-0766

ARVO Annual Meeting Abstract May 2006

Prevalence of Cystoid Macular Edema in Cone Dystrophy and Monitoring Treatment Effects of Acetazolamide Using OCT

D. Barthelmes; F.K. Sutter; M.M. Bosch; H. Helbig; M.M. Kurz–Levin; J.C. Fleischhauer

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1048.

ARVO Annual Meeting Abstract May 2006

Cystoid Macular Edema in Patients With Retinitis Pigmentosa: Monitoring Treatment Effects Using OCT

F.K. Sutter; D. Barthelmes; M.M. Bosch; M.M. Kurz–Levin; H. Helbig; J.C. Fleischhauer

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5192.

ARVO Annual Meeting Abstract May 2006

Exudative Age Related Macular Degeneration Is Not Triggered By Cataract Surgery

H. Helbig; D. Barthelmes; J.C. Fleischhauer; M. Menghini; M.M. Kurz–Levin; M.M. Boesch; F.K. P. Sutter

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2098.

Retina March 2006

Quantitative Analysis of OCT Characteristics in Patients with Achromatopsia and Blue-Cone Monochromatism

PDF

Daniel Barthelmes; Florian K. Sutter; Malaika M. Kurz-Levin; Martina M. Bosch; Horst Helbig; Günter Niemeyer; Johannes C. Fleischhauer
TAGS: acetylcholine, achondroplasia, achromatopsia, retinal cone
Invest. Ophthalmol. Vis. Sci.. 2006; 47(3):1161-1166. https://doi.org/10.1167/iovs.05-0783

ARVO Annual Meeting Abstract May 2005

Quantitative OCT Imaging in Patients With Cone–Dystrophies

J.C. Fleischhauer; D. Barthelmes; F.K. Sutter; M. Kurz–Levin; M.M. Bosch; G. Niemeyer; H. Helbig

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):544.

ARVO Annual Meeting Abstract May 2005

OCT Imaging in Patients With Achromatopsia and Blue–Cone–Monochromatism – A Quantitative Approach to OCT Scanning Results

D. Barthelmes; J.C. Fleischhauer; M. Kurz–Levin; F.K. Sutter; M.M. Bosch; A. Jehn; G. Niemeyer; H. Helbig

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5233.

ARVO Annual Meeting Abstract May 2003

ABCA4 Variations in Patients with Bull's-eye Maculopathy

M.A. Brantley; M.M. Kurz-Levin; C.G. Easterman; B.R. Roos; G.E. Holder; A.C. Bird; E.M. Stone; A.R. Webster

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3560.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Preliminary results of aflibercept in treatment naïve choroidal neovascularization of neovascular age-related macular degeneration

Long-term Studies On The Anti-VEGF Treatment Success In Age-related Macular Degeneration (amd)

Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD

A Swiss Patient Cohort Reveals Genetic Predisposition Of Known And New Genetic Loci To AMD And To Intravitreal Ranibizumab (lucentis®) Treatment Outcome

Ranibizumab for Exudative Age Related Macular Degeneration - A Comparison of Treatment Results in Centres from Australia and Switzerland

Genetic Association of Known Risk Alleles With Different Lesion Types in Age-Related Macular Degeneration

Association Between Response to Intravitreal Ranibizumab and Known AMD Susceptibility Loci in Age-Related Macular Degeneration

Normalization of Functional and Anatomic Changes in Carcinoma Associated Retinopathy

Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization Not Related to Age-Related Macular Degeneration

Towards an Optimized Treatment Scheme of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: Subanalysis of Clinical Trial Data and Clinical Routine Use

Intravitreal Anti-VEGF Therapy in Von Hippel-Lindau Disease With Retinal Angiomas

Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?

Prevalence of Cystoid Macular Edema in Cone Dystrophy and Monitoring Treatment Effects of Acetazolamide Using OCT

Cystoid Macular Edema in Patients With Retinitis Pigmentosa: Monitoring Treatment Effects Using OCT

Exudative Age Related Macular Degeneration Is Not Triggered By Cataract Surgery

Quantitative Analysis of OCT Characteristics in Patients with Achromatopsia and Blue-Cone Monochromatism

Quantitative OCT Imaging in Patients With Cone–Dystrophies

OCT Imaging in Patients With Achromatopsia and Blue–Cone–Monochromatism – A Quantitative Approach to OCT Scanning Results

ABCA4 Variations in Patients with Bull's-eye Maculopathy

To View More...

You must be signed into an individual account to use this feature.